Trump tariffs – Talk Bio

‘Now is not the time to retreat’: BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge

1 month ago talkbio0Tagged Drug Industry, Health Care Reform, Home environment, Manufacturing, Myers, pharmaceutical manufacturing, pharmaceutical tariffs, squibb, Trump tariffs, U.S.

Bristol Myers Squibb, Trump tariffs, pharmaceutical manufacturing, domestic investment, pharmaceutical industry, US manufacturing, healthcare reform, pharmaceutical tariffs

Trump Tariffs Poised to Hit Drug Tool and Packaging Manufacturers: Industry Faces Rising Costs and Supply Chain Challenges

2 months ago talkbio0Tagged alpha 1-antitrypsin, Biopharma trade war, Drug Industry, Drug packaging industry, Generic Drugs, Impact food supplement, lobbying, Manufacturing, Market, onshoring, Pharmaceutical Supply Chain, pharmaceutical tariffs, Supply chain disruption, Trump tariffs, U.S., United States

Trump tariffs , Drug packaging industry , Pharmaceutical supply chain , API manufacturing costs , Biopharma trade war , U.S. manufacturing onshoring , Generic drugs market impact , Pharmaceutical tariffs , Supply chain disruption , Pharmaceutical industry lobbying

Pfizer Prepared to Shift Manufacturing to US in Response to Potential Trump Tariffs

3 months ago talkbio0Tagged Albert, Bourla, Drug Industry, Manufacturing, Pfizer, Trump tariffs, U.S.

Pfizer, Albert Bourla, US manufacturing, Trump tariffs, pharmaceutical industry, reshoring

Pharmaceutical Industry Warns of Drug Shortages and Price Hikes Due to Trump’s New Tariffs

4 months ago talkbio0Tagged Active, APIs, chain disruption, Drug Industry, Drug shortages, Groups, Increased, Prices, TNFRSF19 gene, Trump tariffs

Trump tariffs, drug shortages, price increases, pharmaceutical industry, trade groups, supply chain disruption, generic drugs, active pharmaceutical ingredients (APIs)